CELGENE CORPORATION for CELGENE CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1600 (Patient Access to Treaments Act); oral parity; exclusivity incentives for dormant therapies; proposed changes to FDA-authorized risk evaluation and mitigation strategies
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | Congressional Staff, Rep. Greenwood, 2001-2004 |
| RICHARD T GIRARDS | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER | — |
Trade (domestic/foreign) TRD
negotiations surrounding TPP (Trans-Pacific Partnership) and TTIP (Trans-Atlantic Trade and Investment Partnership); potential grant of Trade Promotion Authority
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD T GIRARDS | — |
Copyright/Patent/Trademark CPT
patent issues in China; patent issues in Canada; issues related to the Patent Trial and Appeal Board; implementation of patent linkage mechanisms; H.R.9 (Innovation Act); S. 632 (STRONG Patents Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | Congressional Staff, Rep. Greenwood, 2001-2004 |
| RICHARD T GIRARDS | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER | — |
Medicare/Medicaid MMM
general issues related to patient access
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | Congressional Staff, Rep. Greenwood, 2001-2004 |
| RICHARD T GIRARDS | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.